Combined treatment of non‐small cell lung cancer using radiotherapy and immunotherapy: challenges and updates
Abstract The efficacy of immunotherapy for advanced non‐small cell lung cancer (NSCLC) remains unsatisfactory, as the majority of patients either do not experience an objective response or acquire secondary resistance. As a result, several methods to enhance the systemic efficacy of immunotherapy ha...
Guardado en:
Autores principales: | Shijie Shang, Jie Liu, Vivek Verma, Meng Wu, James Welsh, Jinming Yu, Dawei Chen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1574272ad6444804a89cd9d61272afb1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Clinical Research Progress of Radiotherapy Combined with Immune Checkpoint Inhibitors on NSCLC
por: ZHU Kuikui, et al.
Publicado: (2021) -
Bibliometric Analysis of the Top-Cited Publications and Research Trends for Stereotactic Body Radiotherapy
por: Yanhao Liu, et al.
Publicado: (2021) -
Recent Research on Combination of Radiotherapy with Targeted Therapy or Immunotherapy in Head and Neck Squamous Cell Carcinoma: A Review for Radiation Oncologists
por: Daniel Tao Xing, et al.
Publicado: (2021) -
Effectiveness of Postoperative or Preoperative Radiotherapy on Prognosis in Patients with Stage II Resectable Non-Small Cell Lung Cancer: A Retrospective Study Based on the SEER Database
por: Deng Chen, et al.
Publicado: (2021) -
Crossed Pathways for Radiation-Induced and Immunotherapy-Related Lung Injury
por: Zengfu Zhang, et al.
Publicado: (2021)